Abstract
With the everincreasing problem of multidrug resistance worldwide, concerns are growing regarding use of alternative compounds to supplement or modify the actions of antibiotics. Along with drug resistance, antibiotics also provide a number of side effects, diarrhea being a very prominent one. Antibiotic associated diarrhea (AAD) is difficult to manage and therefore concepts like ‘probiotics’ have gained importance. In this respect, ‘prebiotics’, which are ‘food’ to ‘feed’ the healthy colonic flora, is an upcoming concept. Because antibiotics alter the normal intestinal flora, controlling the composition of the flora could be truly beneficial. Prebiotics are short chain carbohydrates that can alter the intestinal microbial flora to one rich in bifidobacteria and lactobacilli, the organisms that constitute ‘balanced healthy flora’ and resist gut colonizations by pathogenic flora and infections. The approach seems reasonable. Moreover, prebiotic compounds can be easily incorporated into foodstuffs unlike probiotics. Despite the availability of many natural compounds with prebiotic activity, only inulin and fructo-oligosaccharides have successfully met the criteria to be labeled as prebiotics with substantial evidence. Therefore, it is much early to suppose that prebiotics will markedly change the fate of AADs, even though their potential to restore gut microbial balance is definite. Continuous research studying the effects of more such compounds is required to substantiate the several physiological benefits of prebiotics.
Keywords: AAD, balanced, bifidogenic, colonic, healthy microflora, inulin, prebiotics.
Anti-Infective Agents
Title:Prebiotics: A New Hope Against Antibiotic Associated Diarrhea
Volume: 12 Issue: 2
Author(s): Tuhina Banerjee and Amitabha Bhattacharjee
Affiliation:
Keywords: AAD, balanced, bifidogenic, colonic, healthy microflora, inulin, prebiotics.
Abstract: With the everincreasing problem of multidrug resistance worldwide, concerns are growing regarding use of alternative compounds to supplement or modify the actions of antibiotics. Along with drug resistance, antibiotics also provide a number of side effects, diarrhea being a very prominent one. Antibiotic associated diarrhea (AAD) is difficult to manage and therefore concepts like ‘probiotics’ have gained importance. In this respect, ‘prebiotics’, which are ‘food’ to ‘feed’ the healthy colonic flora, is an upcoming concept. Because antibiotics alter the normal intestinal flora, controlling the composition of the flora could be truly beneficial. Prebiotics are short chain carbohydrates that can alter the intestinal microbial flora to one rich in bifidobacteria and lactobacilli, the organisms that constitute ‘balanced healthy flora’ and resist gut colonizations by pathogenic flora and infections. The approach seems reasonable. Moreover, prebiotic compounds can be easily incorporated into foodstuffs unlike probiotics. Despite the availability of many natural compounds with prebiotic activity, only inulin and fructo-oligosaccharides have successfully met the criteria to be labeled as prebiotics with substantial evidence. Therefore, it is much early to suppose that prebiotics will markedly change the fate of AADs, even though their potential to restore gut microbial balance is definite. Continuous research studying the effects of more such compounds is required to substantiate the several physiological benefits of prebiotics.
Export Options
About this article
Cite this article as:
Banerjee Tuhina and Bhattacharjee Amitabha, Prebiotics: A New Hope Against Antibiotic Associated Diarrhea, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/2211352511999131128152601
DOI https://dx.doi.org/10.2174/2211352511999131128152601 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Using Biologic Agents in Pediatric Rheumatologic Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis
Recent Patents on CNS Drug Discovery (Discontinued) Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Current Pharmaceutical Design Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Current Drug Targets Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Chronic Inflammation in the Pancreas and Salivary Glands - Lessons from Similarities and Differences in Pathophysiology and Treatment Modalities
Current Pharmaceutical Design Iron Deficiency: The Hidden Miscreant in Inflammatory Bowel Disease
Current Drug Targets Polyamines in Gut Inflammation and Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Radiosensitization of Prostate Cancer by Soy Isoflavones
Current Cancer Drug Targets Psoriasis in Children: A Review
Current Pediatric Reviews Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology Evidence of Probiotics in Prevention of Allergy and Asthma
Current Drug Targets - Inflammation & Allergy Current Treatment of Relapsed Ovarian Carcinoma
Current Cancer Therapy Reviews COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer
Current Pharmaceutical Design Structural Requirements of Heparin and Related Molecules to Exert a Multitude of Anti-Inflammatory Activities
Mini-Reviews in Medicinal Chemistry The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
Current Neuropharmacology